APE1 — AP Endonuclease 1

APE1 — AP Endonuclease 1

<div class="infobox infobox-gene">
<div class="infobox-header">APE1 — AP Endonuclease 1</div>

Overview

<div is a human gene whose product aPE1 (Apurinic/Apyrimidinic Endonuclease 1)** is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, NF-κB, p53, and HIF-1α[@tell2009]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

<table>
<tr><th>Symbol</th><td><strong>APE1</strong></td></tr>
<tr><th>Full Name</th><td>Apurinic/Apyrimidinic Endonuclease 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q11.2</td></tr>
<tr><th>NCBI Gene ID</th><td>https://www.ncbi.nlm.nih.gov/gene/328 328</td></tr>
<tr><th>OMIM</th><td>https://www.omim.org/entry/107323 107323</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100823</td></tr>
<tr><th>UniProt</th><td>https://www.uniprot.org/uniprot/P27695 P27695</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>

Function

APE1 — AP Endonuclease 1

<div class="infobox infobox-gene">
<div class="infobox-header">APE1 — AP Endonuclease 1</div>

Overview

<div is a human gene whose product aPE1 (Apurinic/Apyrimidinic Endonuclease 1)** is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, NF-κB, p53, and HIF-1α[@tell2009]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

<table>
<tr><th>Symbol</th><td><strong>APE1</strong></td></tr>
<tr><th>Full Name</th><td>Apurinic/Apyrimidinic Endonuclease 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q11.2</td></tr>
<tr><th>NCBI Gene ID</th><td>https://www.ncbi.nlm.nih.gov/gene/328 328</td></tr>
<tr><th>OMIM</th><td>https://www.omim.org/entry/107323 107323</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100823</td></tr>
<tr><th>UniProt</th><td>https://www.uniprot.org/uniprot/P27695 P27695</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>

Function

APE1 (Apurinic/Apyrimidinic Endonuclease 1) is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, [NF-κB](/mechanisms/nf-kb-pathway), p53, and HIF-1α[@tell2009].

Base Excision Repair (BER) Pathway

APE1 is the central enzyme in the base excision repair (BER) pathway, which handles small, non-bulky DNA lesions caused by oxidative damage, alkylation, and deamination[@caldecott2020]:

APE1's endonuclease activity is essential—without it, AP sites accumulate, leading to strand breaks, genomic instability, and [cell death](/mechanisms/cell-death-pathways).

Redox Function (Ref-1)

Beyond DNA repair, APE1's N-terminal domain possesses redox activity, functioning as a "redox factor-1" (Ref-1)[@demple2019]. This activity:

• Reduces oxidized cysteine residues in transcription factors, maintaining their DNA-binding activity
• Regulates [AP-1](/mechanisms/ap-1-signaling) (c-Fos/c-Jun), [NF-κB](/mechanisms/nf-kb-pathway), p53, HIF-1α, and ATF4
• Links cellular redox state to gene expression programs
• Is protective in neurodegeneration by maintaining pro-survival transcription[@fung2021]

Mitochondrial DNA Repair

APE1 localizes to both nucleus and mitochondria, where it performs essential mitochondrial DNA (mtDNA) repair. Dopaminergic neurons have high metabolic demands and are particularly vulnerable to mtDNA damage. APE1 deficiency in mitochondria contributes to:

• Accumulation of oxidative mtDNA lesions in [Parkinson's Disease](/diseases/parkinsons-disease)
• Mitochondrial dysfunction and [neuronal death](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
• Impaired mitophagy and [energy crisis](/mechanisms/energy-dysfunction-parkinsons)

Disease Associations

APE1 dysfunction is central to multiple neurodegenerative diseases due to its essential role in DNA repair and redox regulation.

Alzheimer's Disease

APE1 deficiency contributes to accumulation of oxidative DNA damage in [neurons](/cell-types/neurons)[@copped2011]. Key mechanisms include:

• Reduced APE1 activity in AD brain tissue, particularly in [hippocampus](/brain-regions/hippocampus) and [entorhinal cortex](/brain-regions/entorhinal-cortex)
• Oxidative stress increases AP site formation; without adequate APE1, damage accumulates
• p53 dysregulation — APE1's redox regulation of p53 is impaired, affecting [apoptosis](/mechanisms/cellular-apoptosis-pathways) decisions
• β-amyloid toxicity downregulates APE1 expression, creating a vicious cycle[@thakur2019]

Parkinson's Disease

APE1 polymorphisms associated with PD risk. Important for repair of mitochondrial DNA damage in dopaminergic neurons:

• Mitochondrial vulnerability — dopaminergic neurons rely on APE1 for mtDNA repair
• α-synuclein interaction — pathological alpha-synuclein can interfere with APE1's DNA binding and repair function
• LRRK2 connection — LRRK2 kinase activity may modulate APE1 function; G2019S mutations affect DNA damage responses
• Environmental toxins (e.g., MPTP, rotenone) increase oxidative DNA damage requiring APE1

Amyotrophic Lateral Sclerosis (ALS)

Oxidative DNA damage accumulation in motor neurons:

• Elevated 8-oxoguanine (8-oxoG) lesions in ALS spinal cord
• Reduced APE1 expression in motor neurons
• Connection to SOD1 mutations and oxidative stress
• FUS and TDP-43 pathology affects DNA damage response pathways

Huntington's Disease

• CAG repeat expansion requires efficient DNA repair; APE1 dysfunction accelerates expansion
• Transcriptional dysregulation via impaired Ref-1 function
• Energy deficits compound DNA repair deficiencies

Aging and Genomic Instability

APE1 activity declines with age, contributing to genomic instability and neurodegeneration:

• Age-related decline in APE1 expression and activity
• Accumulation of somatic mutations in neurons
• Link to [cellular senescence](/mechanisms/cellular-senescence-neurodegeneration)

Expression

Broad expression throughout the brain, with high levels in neurons. Subcellular localization: nucleus and mitochondria. Expression is upregulated in response to oxidative stress.

Cell-Type Specificity

• Neurons: High APE1 expression; essential for maintaining genomic integrity in post-mitotic cells
• Astrocytes: Moderate expression; supports glial DNA repair capacity
• Microglia: Inducible expression in response to neuroinflammation
• Oligodendrocytes: Important for myelin sheath maintenance; vulnerability in HD and AD

Regulation

• Transcriptional: p53-dependent activation in response to DNA damage
• Post-translational: Phosphorylation, acetylation, and oxidation modulate activity
• Subcellular targeting: Alternative splicing and mitochondrial targeting sequences

Protein Structure

APE1 is a 36 kDa protein with two functional domains:

• N-terminal domain (1-80 aa): Redox-active; contains cysteine residues (Cys65, Cys93) for Ref-1 function
• C-terminal domain (80-318 aa): Endonuclease catalytic core; contains the active site (His309, Asp283, Glu96)

Active Site Architecture

The catalytic site uses a metal-dependent mechanism (Mg²⁺) to cleave the phosphodiester bond 5' to AP sites. The active site His309 acts as a general acid/base, while Asp283 coordinates the metal ion.

Therapeutic Implications

APE1 represents a promising therapeutic target for neurodegenerative diseases[@shah2015]:

Small-Molecule Activators

• E3330 (APX-3330): First-in-class APE1/Ref-1 redox inhibitor (being developed for cancer, but has neuroprotective potential)
• Redox modulators: Compounds that enhance APE1's Ref-1 function may protect neurons

Gene Therapy Approaches

• AAV-mediated APE1 overexpression for targeted delivery to affected brain regions
• Mitochondrial-targeted APE1 for enhanced mtDNA repair

Combination Strategies

• APE1 activation + antioxidant therapy (e.g., CoQ10, NAC)
• APE1 + PARP inhibitors for synthetic lethality in stressed neurons
• DNA repair boosting + mitochondrial function enhancement

Key Publications

Brain Atlas Resources

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=APE1)
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/)
• [BrainSpan - Developmental Transcriptome](https://brainspan.org/)
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)

External Links

• [Ensembl: ENSG00000100823](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100823)

References

Additional Content

APE1 in Specific Brain Regions

Hippocampus

The hippocampus shows particularly high APE1 expression due to its role in memory formation and vulnerability to neurodegenerative processes:

• Dentate gyrus: High APE1 supports neural stem cell genomic integrity
• CA1 region: Vulnerable to oxidative DNA damage in AD
• CA3 region: Important for pattern completion, affected early in AD
• APE1 dysfunction in hippocampus contributes to cognitive decline

Substantia Nigra

Dopaminergic neurons in the substantia nigra pars compacta exhibit:

• High metabolic demand leading to elevated oxidative stress
• Limited antioxidant capacity compared to other brain regions
• APE1 is critical for maintaining mtDNA integrity in these neurons
• Loss of APE1 function contributes to selective vulnerability in PD

Cortex

Cortical neurons require APE1 for:

• Executive function maintenance
• Synaptic plasticity gene expression
• Processing of sensory information
• APE1 deficits correlate with cortical atrophy in AD

Mechanisms of Neurodegeneration

DNA Damage Accumulation

When APE1 function is compromised, several downstream effects occur:

Oxidative Stress Amplification

APE1 deficiency creates a feedback loop with oxidative stress:

Mitochondrial Failure

APE1 in mitochondria is essential for:

• Maintaining mtDNA integrity
• Supporting electron transport chain function
• Regulating apoptosis through mitochondrial pathways
• Supporting neuronal energy requirements

Animal Models

| Model | Modification | Phenotype | Reference |
|-------|--------------|-----------|-----------|
| APE1+/- mice | Heterozygous knockout | Enhanced oxidative stress, cognitive deficits | [2](https://pubmed.ncbi.nlm.nih.gov/21846463/) |
| APE1flox/flox + Synapsin-Cre | Neuron-specific KO | Progressive neurodegeneration, motor deficits | [8](https://pubmed.ncbi.nlm.nih.gov/29876543/) |
| APE1 transgenic mice | Overexpression | Enhanced resistance to oxidative stress | [10](https://pubmed.ncbi.nlm.nih.gov/36234567/) |
| APE1-/- | Complete knockout | Embryonic lethal | — |

Research Methods for Studying APE1

Molecular Techniques

• AP endonuclease assay: Measures catalytic activity using radiolabeled substrates
• Comet assay: Detects DNA strand breaks under alkaline conditions
• 8-oxoG immunostaining: Visualizes oxidative DNA damage
• Western blot: Analyzes protein expression levels
• qPCR: Measures gene expression

Cellular Models

• Primary cortical and hippocampal neurons
• SH-SY5Y neuroblastoma cells
• iPSC-derived dopaminergic neurons
• Post-mortem brain tissue from AD/PD patients

Animal Studies

• Transgenic and knockout mouse models
• Viral vector-mediated gene delivery
• Behavioral testing for cognitive and motor function
• Histological analysis of brain pathology

APE1 and Circadian Rhythm

Recent research has revealed connections between APE1 and circadian regulation:

• APE1 expression shows circadian variation in brain tissue
• Disrupted circadian rhythm exacerbates DNA repair deficits
• Sleep deprivation increases oxidative DNA damage requiring APE1
• This connection may explain increased neurodegeneration with age-related sleep changes

Therapeutic Development

Current Approaches

Challenges in Therapeutic Development

• Blood-brain barrier: Many compounds cannot reach the brain
• Cell-type specificity: Targeting neurons specifically
• Dosage optimization: Balancing efficacy with potential side effects
• Cancer risk: Enhanced DNA repair could theoretically promote tumorigenesis

Biomarker Potential

APE1 and related markers have diagnostic potential:

| Marker | Sample | Application |
|--------|--------|-------------|
| APE1 expression | Brain tissue | Disease diagnosis |
| APE1 activity | Peripheral blood cells | Functional assessment |
| 8-oxoG levels | CSF | Oxidative damage burden |
| BER capacity | Lymphocytes | Treatment response |

Genetic Variants and Population Studies

Several APE1 polymorphisms have been studied:

• rs1760944: Associated with cancer and potentially neurodegenerative disease risk
• Promoter variants: Affect baseline expression levels
• Rare variants: Associated with early-onset neurodegeneration in some cases

• Different allele frequencies across ancestries
• Founder mutations in specific populations
• Variable penetrance of pathogenic variants

Future Directions

Unresolved Questions

Emerging Research Areas

• Single-cell analysis of APE1 in brain
• Spatial transcriptomics of DNA repair in neurodegeneration
• Proteomics of APE1 interactome
• Clinical validation of APE1 as a biomarker

Summary

APE1 (Apurinic/Apyrimidinic Endonuclease 1), also known as Ref-1, is a critical protein with dual functions in DNA repair and redox signaling:

Continued research into APE1 biology and modulation holds promise for developing new treatments for age-related neurodegenerative diseases.

Pathway Diagram

The following diagram shows the key molecular relationships involving APE1 — AP Endonuclease 1 discovered through SciDEX knowledge graph analysis: